2024 Q4 Form 10-Q Financial Statement

#000109690624002079 Filed on November 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $15.27K
YoY Change -6.34%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $15.27K
YoY Change -6.34%
Operating Profit -$15.27K
YoY Change -6.34%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$15.27K
YoY Change -6.34%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$15.27K
YoY Change -6.34%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 1.530M shares 1.530M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $217.7K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $220.5K
YoY Change -25.18%
LONG-TERM ASSETS
Property, Plant & Equipment $34.50K
YoY Change 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $34.50K
YoY Change 0.0%
TOTAL ASSETS
Total Short-Term Assets $220.5K
Total Long-Term Assets $34.50K
Total Assets $255.0K
YoY Change -22.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.000K
YoY Change -61.9%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.000K
Total Long-Term Liabilities
Total Liabilities $4.000K
YoY Change -61.9%
SHAREHOLDERS EQUITY
Retained Earnings -$196.1K
YoY Change 52.76%
Common Stock $1.530K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $251.0K
YoY Change
Total Liabilities & Shareholders Equity $255.0K
YoY Change -22.54%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$15.27K
YoY Change -6.34%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Registrant Name
EntityRegistrantName
Circle Energy, Inc./NV
dei Entity Central Index Key
EntityCentralIndexKey
0001911467
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56587
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-4125972
dei Entity Address Address Line1
EntityAddressAddressLine1
8211 E Regal Place
dei Entity Address City Or Town
EntityAddressCityOrTown
Tulsa
dei Entity Address State Or Province
EntityAddressStateOrProvince
OK
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
74133
dei City Area Code
CityAreaCode
918
dei Local Phone Number
LocalPhoneNumber
994-0693
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1530000 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
217677 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
261338 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2814 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14519 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
220491 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
275857 usd
CY2024Q3 fil Oil And Natural Gas Properties Not Subject To Amortization
OilAndNaturalGasPropertiesNotSubjectToAmortization
34500 usd
CY2023Q4 fil Oil And Natural Gas Properties Not Subject To Amortization
OilAndNaturalGasPropertiesNotSubjectToAmortization
34500 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34500 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34500 usd
CY2024Q3 us-gaap Assets
Assets
254991 usd
CY2023Q4 us-gaap Assets
Assets
310357 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7995 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7995 usd
CY2024Q3 us-gaap Liabilities
Liabilities
4000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
7995 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1530000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1530000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1530000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1530000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1530 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1530 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
445533 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
445533 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-196072 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-144701 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
250991 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
302362 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
254991 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
310357 usd
CY2024Q3 us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15273 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16306 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
51371 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
62035 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
15273 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
16306 usd
us-gaap Operating Expenses
OperatingExpenses
51371 usd
us-gaap Operating Expenses
OperatingExpenses
62035 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-15273 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-16306 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-51371 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-62035 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15273 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16306 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-51371 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-62035 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-15273 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-16306 usd
us-gaap Net Income Loss
NetIncomeLoss
-51371 usd
us-gaap Net Income Loss
NetIncomeLoss
-62035 usd
CY2024Q3 fil Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.01
CY2023Q3 fil Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.01
fil Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.03
fil Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.04
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
380742 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-24496 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
356246 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-21233 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
335013 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-16306 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
318707 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
302362 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-24051 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
278311 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-12047 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
266264 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-15273 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
250991 usd
us-gaap Net Income Loss
NetIncomeLoss
-51371 usd
us-gaap Net Income Loss
NetIncomeLoss
-62035 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-11705 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-9264 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3995 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6987 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43661 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-45784 usd
us-gaap Payments To Acquire Oil And Gas Property
PaymentsToAcquireOilAndGasProperty
0 usd
us-gaap Payments To Acquire Oil And Gas Property
PaymentsToAcquireOilAndGasProperty
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-43661 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-45784 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
261338 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
336241 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
217677 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
290457 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font:10pt Times New Roman;margin:0;text-align:justify"><b><i>Use of Estimates</i></b> – The preparation of financial statements in conformity with “U.S. GAAP” requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Changes in the future estimated oil and natural gas reserves or the estimated future cash flows attributable to the reserves that are utilized for impairment analysis could have a significant impact on the future results of operations.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font:10pt Times New Roman;margin:0;text-align:justify"><b><i>Concentration of Credit Risk and Accounts Receivable</i></b> – Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and accounts receivable. The Company places its cash with a high credit quality financial institution.</p>
CY2024Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3424 usd
CY2023Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
13027 usd
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
41175 usd
fil Monthly Lease Payment
MonthlyLeasePayment
79 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-15273 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-16306 usd
us-gaap Net Income Loss
NetIncomeLoss
-51371 usd
us-gaap Net Income Loss
NetIncomeLoss
-62035 usd
CY2024Q3 fil Basic And Diluted Weighted Average Shares Outstanding
BasicAndDilutedWeightedAverageSharesOutstanding
1530000 shares
CY2023Q3 fil Basic And Diluted Weighted Average Shares Outstanding
BasicAndDilutedWeightedAverageSharesOutstanding
1530000 shares
fil Basic And Diluted Weighted Average Shares Outstanding
BasicAndDilutedWeightedAverageSharesOutstanding
1530000 shares
fil Basic And Diluted Weighted Average Shares Outstanding
BasicAndDilutedWeightedAverageSharesOutstanding
1530000 shares
CY2024Q3 fil Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.01
CY2023Q3 fil Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.01
fil Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.03
fil Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.04

Files In Submission

Name View Source Status
0001096906-24-002079-index-headers.html Edgar Link pending
0001096906-24-002079-index.html Edgar Link pending
0001096906-24-002079.txt Edgar Link pending
0001096906-24-002079-xbrl.zip Edgar Link pending
crcl-20240930.htm Edgar Link pending
crcl-20240930.xsd Edgar Link pending
crcl_ex31z1.htm Edgar Link pending
crcl-20240930_lab.xml Edgar Link unprocessable
crcl-20240930_pre.xml Edgar Link unprocessable
crcl-20240930_htm.xml Edgar Link completed
crcl_ex31z2.htm Edgar Link pending
crcl_ex32z1.htm Edgar Link pending
crcl_ex32z2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
crcl-20240930_def.xml Edgar Link unprocessable
crcl-20240930_cal.xml Edgar Link unprocessable